“…Pharmacological inhibitors are commonly used for this purpose; while they work quickly and are usually reversible, available drugs can access only a limited portion of the proteome, typically can only deactivate protein function, and may have off‐target effects . Other techniques, including bump‐and‐hole approaches, chemically induced dimerization and dissociation, and controlled degradation have expanded conditional control over protein function. Here, we present an optimized and generally applicable approach that does not require small‐molecule ligand discovery, molecular engineering of the ligand, or genetically fused ligand‐binding domains, while enabling rapid OFF to ON switching of protein function with complete specificity.…”